If you would like this piece read to you, just click above Once covid had really started, and we received our daily dose of Boris Johnson and his clowns ...

Abecma improved multiple quality of life aspects in patients with pretreated myeloma, research showed.Abecma (idecabtagene vicleucel) significantly improved ...

Treatment with Brukinsa (zanubrutinib) led to better progression-free survival (PFS; time from treatment until disease worsening or death) compared with ...

Safety and efficacy of Tecvayli for patients with relapsed/refractory multiple myeloma tended to be similar in the real-world setting as it was in the phase ...

Patients with early-stage breast cancer tended to experience event-free survival benefits with Keytruda plus chemothearpy.Patients with high-risk, ...

Tecartus was safe and effective in a real-world population of patients with high-risk, relapsed/refractory mantle cell lymphoma.For patients with ...

An all-oral regimen showed overall survival and relapse-free survival benefits in patients with acute promyelocytic leukemia. Treatment with an all-oral ...

During its 11th annual MPN Heroes® recognition event, CURE® honored the contributions of eight individuals who made a difference in the field of ...

Presurgical Opdivo and chemo led to promising pathologic complete response rates in early-stage breast cancer.Neoadjuvant (administered before surgery) ...

Zanidatamab, Ibrance (palbociclib) and tFaslodex (fulvestrant) had promising progression-free survival results and a manageable safety profile among ...